MY
Noveris Health Sciences Inc.
MYCOF · OTC
$0.73 +0.00% (+$0.00)
Market Cap $60.0M
P/E Ratio 36.70x
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
6 /100
Expensive EV/EBITDA 27.69x
P/E 36.70x
PEG N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
79 /100
Excellent ROA 165.32%
Asset turnover 0.00x
ROIC 49.67%
Debt
79 /100
Low Int. coverage 46.96x
Net debt/EBITDA -0.20x
Current ratio 0.31x
Stability
50 /100
Moderate Beta -5.44x
EPS volatility N/A
Profitable years N/A
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na MYCOF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Jason Birmingham
Employees
3
Headquarters
Vancouver
Nadcházející události
17 LIS
Earnings
Upcoming earnings report